A case of acquired Fanconi^|^apos;s syndrome and hypophosphatemic osteomalacia induced by prolonged adefovir therapy for chronic hepatitis B-Reference-Cited by-同舟云学术

A case of acquired Fanconi^|^apos;s syndrome and hypophosphatemic osteomalacia induced by prolonged adefovir therapy for chronic hepatitis B

Published:2014 Issue:3 Volume:55 Page:162-169
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Kanzo

Author:

Ishikawa Kazuma,Miyanishi Koji,Hoki Toshifumi,Tamura Fumito,Kawano Yutaka,Takada Kohichi,Tanaka Shingo,Sakurada Akira,Sato Yasushi,Sato Tsutomu,Hayashi Tsuyoshi,Takimoto Risyu,Kobune Masayoshi,Kato Junji

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/55/3/55_162/_pdf

Reference34 articles.

1. 1) Kahn J, Lagakos S, Wulfsohn M, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA 1999; 282: 2305-2312

2. 2) Fisher EJ, Chaloner K, Cohn DL, et al. The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized placebo-controlled trial. AIDS 2001; 15: 1695-1700

3. 3) Marcellin P, Chang TT, Lim SG, et al. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Hepatology 2008; 48: 750-758

4. 4) Lampertico P, Vigano M, Menenti E, et al. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. Gastroenterology 2007; 133: 1445-1451

5. 5) Yatsuji H, Suzuki F, Sezaki H, et al. Low risk of adefovir resistance of lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up. J Hepatol 2008; 48: 923-931

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal impairment and hypophosphatemia in chronic hepatitis B patients treated with adefovir dipivoxil;Kanzo;2016

2. Adefovir dipivoxil;Reactions Weekly;2014-05